Freezing Tenecteplase Into Aliquots to Reduce Waste in Acute Ischemic Stroke

Stroke. 2024 Jan;55(1):e1-e2. doi: 10.1161/STROKEAHA.123.044345. Epub 2023 Dec 8.

Authors

Harsimran Kaur¹, Alison Merkel², Christopher T Hackett¹, Lauren Finoli², Edward Seidl², Caitlin Reardon², Russell Cerejo¹

Affiliations

¹ AHN Neuroscience Institute, Allegheny Health Network, Pittsburgh, PA (H.K., C.T.H., R.C.).
² AHN Pharmacy, Allegheny General Hospital, Pittsburgh, PA (A.M., L.F., E.S., C.R.).

PMID: 38063015
DOI: 10.1161/STROKEAHA.123.044345

No abstract available

Keywords: ischemic stroke; myocardial infarction; pharmacy; prospective studies; thrombectomy.

MeSH terms

Brain Ischemia* / drug therapy
Fibrinolytic Agents / therapeutic use
Freezing
Humans
Ischemic Stroke* / drug therapy
Stroke* / drug therapy
Tenecteplase / therapeutic use
Tissue Plasminogen Activator / therapeutic use
Treatment Outcome

Substances

Tenecteplase
Fibrinolytic Agents
Tissue Plasminogen Activator